• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

风湿性心脏病从全球卫生议程中缺失。

Rheumatic Heart Disease is Missing from the Global Health Agenda.

机构信息

Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, TN, US.

Vanderbilt Institute for Global Health (VIGH), Nashville, TN, US.

出版信息

Ann Glob Health. 2021 Nov 17;87(1):110. doi: 10.5334/aogh.3426. eCollection 2021.

DOI:10.5334/aogh.3426
PMID:34824991
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8603858/
Abstract

Rheumatic heart disease (RHD) is a complication of untreated throat infection by Group A beta-hemolytic streptococcus with a high prevalence among socioeconomically disadvantaged populations. Despite its high incidence and prevalence, RHD prevention is not a priority in major global health discussions. The reasons for the apparent neglect are multifactorial, including underestimated morbidity and mortality burden, underappreciated economic burden, lack of public awareness, and lack of sustainable investment. In this review, we recommend multisectoral collaboration to tackle the burden of RHD by engaging the public, health experts, and policymakers; augmenting funding for clinical care; improving distribution channels for prophylaxis, and increasing research and innovation as critical interventions to save millions of people from preventable morbidity and mortality.

摘要

风湿性心脏病(RHD)是 A 组β溶血性链球菌未经治疗的咽喉感染的并发症,在社会经济处于不利地位的人群中发病率较高。尽管风湿性心脏病的发病率和患病率都很高,但它在主要的全球卫生讨论中并不是优先事项。造成这种明显忽视的原因是多方面的,包括发病率和死亡率负担被低估、经济负担被低估、公众意识不足以及缺乏可持续投资。在这篇综述中,我们建议通过让公众、卫生专家和政策制定者参与、增加临床护理资金、改善预防措施的分配渠道以及增加研究和创新,来开展多部门合作,以应对风湿性心脏病的负担,这些都是挽救数百万人免受可预防的发病率和死亡率的关键干预措施。

相似文献

1
Rheumatic Heart Disease is Missing from the Global Health Agenda.风湿性心脏病从全球卫生议程中缺失。
Ann Glob Health. 2021 Nov 17;87(1):110. doi: 10.5334/aogh.3426. eCollection 2021.
2
Echocardiographic prevalence of rheumatic heart disease in Brazilian schoolchildren: Data from the PROVAR study.巴西学童风湿性心脏病的超声心动图患病率:来自PROVAR研究的数据。
Int J Cardiol. 2016 Sep 15;219:439-45. doi: 10.1016/j.ijcard.2016.06.088. Epub 2016 Jun 23.
3
Generating Global Priority for Addressing Rheumatic Heart Disease: A Qualitative Policy Analysis.生成解决风湿性心脏病的全球优先事项:定性政策分析。
J Am Heart Assoc. 2020 Apr 21;9(8):e014800. doi: 10.1161/JAHA.119.014800. Epub 2020 Apr 20.
4
Persisting burden and challenges of rheumatic heart disease.风湿性心脏病的持续负担和挑战。
Eur Heart J. 2021 Sep 7;42(34):3338-3348. doi: 10.1093/eurheartj/ehab407.
5
Incidence, prevalence and outcomes of rheumatic heart disease in South Africa: a systematic review protocol.南非风湿性心脏病的发病率、患病率及转归:一项系统评价方案
BMJ Open. 2014 Jun 10;4(6):e004844. doi: 10.1136/bmjopen-2014-004844.
6
Secondary prophylaxis to control rheumatic heart disease in developing countries: Put into a cage if can't be killed.发展中国家控制风湿性心脏病的二级预防:若无法根除则加以控制。 (不过你提供的英文原文表述比较奇特且有点费解,正常的医学文献表述应该不会这么奇怪)
Indian Heart J. 2018 Nov-Dec;70(6):907-910. doi: 10.1016/j.ihj.2018.01.001. Epub 2018 Jan 8.
7
Rheumatic Heart Disease: The Unfinished Global Agenda.风湿性心脏病:未竟的全球议程。
Cardiol Clin. 2017 Feb;35(1):165-180. doi: 10.1016/j.ccl.2016.08.006.
8
Tertiary prevention and treatment of rheumatic heart disease: a National Heart, Lung, and Blood Institute working group summary.风湿性心脏病的三级预防与治疗:美国国立心肺血液研究所工作组总结。
BMJ Glob Health. 2023 Oct;8(Suppl 9). doi: 10.1136/bmjgh-2023-012355.
9
Integrating the Prevention and Control of Rheumatic Heart Disease into Country Health Systems: A Systematic Review and Meta-Analysis.将风湿性心脏病的预防与控制纳入国家卫生系统:一项系统评价和荟萃分析
Glob Heart. 2020 Sep 14;15(1):62. doi: 10.5334/gh.874.
10
Present status of rheumatic fever and rheumatic heart disease in India.印度风湿热和风湿性心脏病的现状
Indian Heart J. 1995 Jul-Aug;47(4):395-8.

引用本文的文献

1
Adherence to benzathine penicillin prophylaxis and associated factors in patients with rheumatic heart disease attending two public hospitals in Bahir dar, Ethiopia.埃塞俄比亚巴赫达尔两家公立医院风湿性心脏病患者对苄星青霉素预防治疗的依从性及相关因素
BMC Cardiovasc Disord. 2025 Aug 9;25(1):594. doi: 10.1186/s12872-025-05069-w.
2
Rheumatic heart disease burden and determinants in cardiac patients: A follow up care concern in Ethiopia.心脏病患者的风湿性心脏病负担及决定因素:埃塞俄比亚的后续护理问题
Int J Cardiol Cardiovasc Risk Prev. 2024 Nov 21;24:200352. doi: 10.1016/j.ijcrp.2024.200352. eCollection 2025 Mar.
3
At the Heart of the Community: Implementation of Echocardiographic Screening for Rheumatic Heart Disease in Primary Care Facilities of Northern Borneo Island.社区心脏:北婆罗洲岛基层医疗设施中心脏超声筛查风湿性心脏病的实施情况。
J Prim Care Community Health. 2024 Jan-Dec;15:21501319241233178. doi: 10.1177/21501319241233178.
4
Recommendations for developing effective and safe paediatric and congenital heart disease services in low-income and middle-income countries: a public health framework.为中低收入国家制定有效和安全的儿科及先天性心脏病服务的建议:公共卫生框架。
BMJ Glob Health. 2023 May;8(5). doi: 10.1136/bmjgh-2023-012049.
5
Genetic Evidence Supporting Causal Roles of mTOR-Dependent Proteins in Rheumatic Fever: A Two-Sample Randomized Mendelian Study.支持mTOR依赖蛋白在风湿热中因果作用的遗传证据:一项两样本随机孟德尔研究。
Adv Ther. 2023 Apr;40(4):1590-1600. doi: 10.1007/s12325-022-02419-4. Epub 2023 Feb 11.
6
Analysis of Rheumatic Heart Disease Mortality in the Chinese Population: A JoinPoint and Age-Period-Cohort Study.风湿性心脏病在中国人群中的死亡率分析:联合点和年龄-时期-队列研究。
Int J Environ Res Public Health. 2022 Aug 10;19(16):9872. doi: 10.3390/ijerph19169872.
7
Contemporary prevalence and outcomes of rheumatic mitral valve surgery.风湿性二尖瓣手术的当代患病率和结局。
J Card Surg. 2022 Jul;37(7):1868-1874. doi: 10.1111/jocs.16369. Epub 2022 Feb 26.

本文引用的文献

1
Household Economic Consequences of Rheumatic Heart Disease in Uganda.乌干达风湿性心脏病的家庭经济后果
Front Cardiovasc Med. 2021 Jul 30;8:636280. doi: 10.3389/fcvm.2021.636280. eCollection 2021.
2
Rising Ethnic Inequalities in Acute Rheumatic Fever and Rheumatic Heart Disease, New Zealand, 2000-2018.2000-2018 年新西兰急性风湿热和风湿性心脏病中种族不平等现象日益加剧。
Emerg Infect Dis. 2021 Jan;27(1):36-46. doi: 10.3201/eid2701.191791.
3
Contemporary Incidence and Prevalence of Rheumatic Fever and Rheumatic Heart Disease in Australia Using Linked Data: The Case for Policy Change.利用关联数据评估澳大利亚风湿热和风湿性心脏病的当代发病率和流行率:政策改革势在必行。
J Am Heart Assoc. 2020 Oct 20;9(19):e016851. doi: 10.1161/JAHA.120.016851. Epub 2020 Sep 14.
4
Economic consequences of rheumatic heart disease: A scoping review.风湿性心脏病的经济后果:范围综述。
Int J Cardiol. 2021 Jan 15;323:235-241. doi: 10.1016/j.ijcard.2020.09.020. Epub 2020 Sep 10.
5
Generating Global Priority for Addressing Rheumatic Heart Disease: A Qualitative Policy Analysis.生成解决风湿性心脏病的全球优先事项:定性政策分析。
J Am Heart Assoc. 2020 Apr 21;9(8):e014800. doi: 10.1161/JAHA.119.014800. Epub 2020 Apr 20.
6
The cost-of-illness due to rheumatic heart disease: national estimates for Fiji.风湿性心脏病所致疾病负担:斐济国家估计数。
Trans R Soc Trop Med Hyg. 2020 Jul 1;114(7):483-491. doi: 10.1093/trstmh/trz118.
7
Neglecting the neglected: the objective evidence of underfunding in rheumatic heart disease.忽视被忽视的问题:风湿性心脏病资金不足的客观证据。
Trans R Soc Trop Med Hyg. 2019 May 1;113(5):287-290. doi: 10.1093/trstmh/trz014.
8
WHO Resolution on rheumatic heart disease.世界卫生组织关于风湿性心脏病的决议。
Eur Heart J. 2018 Dec 21;39(48):4233. doi: 10.1093/eurheartj/ehy764.
9
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家层面 195 个国家和地区 1990 年至 2017 年 354 种疾病和伤害导致的发病率、患病率和伤残损失寿命年:基于 2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1789-1858. doi: 10.1016/S0140-6736(18)32279-7. Epub 2018 Nov 8.
10
Rheumatic heart disease awareness in the South West region of Cameroon: A hospital based survey in a Sub-Saharan African setting.喀麦隆西南部风湿性心脏病认知情况调查:撒哈拉以南非洲地区的医院调查。
PLoS One. 2018 Sep 25;13(9):e0203864. doi: 10.1371/journal.pone.0203864. eCollection 2018.